| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Medicine and the Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School [P. C. C., A. T., G. K., Y. M., H. H., K. T., R. V., E. D. Z., S. H., P. K. S., M. B. E., M. D., M. S., M. P., V. P. S., R. K.], and Dana Farber Cancer Institute and Harvard Medical School [D. W. K.], Boston, Massachusetts 02215, and Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637 [R. R. W.]
Vascular basement membrane is an important structural component of blood
vessels and has been shown to interact with and modulate vascular
endothelial behavior during angiogenesis. During the inductive phase of
tumor angiogenesis, this membrane undergoes many degradative and
structural changes and reorganizes to a native state around newly
formed capillaries in the resolution phase. Such matrix changes are
potentially associated with molecular modifications that include
expression of matrix gene products coupled with conformational changes,
which expose cryptic protein modules for interaction with the vascular
endothelium. We speculate that these interactions provide important
endogenous angiogenic and anti-angiogenic cues. In this report, we
identify an important anti-angiogenic vascular basement
membrane-associated protein, the 26-kDa NC1 domain of the
1 chain of type IV collagen, termed arresten. Arresten
was isolated from human placenta and produced as a recombinant molecule
in Escherichia coli and 293 embryonic kidney cells. We
demonstrate that arresten functions as an anti-angiogenic molecule by
inhibiting endothelial cell proliferation, migration, tube formation,
and Matrigel neovascularization. Arresten inhibits the growth of two
human xenograft tumors in nude mice and the development of tumor
metastases. Additionally, we show that the anti-angiogenic activity of
arresten is potentially mediated via mechanisms involving cell surface
proteoglycans and the 1ß1 integrin on
endothelial cells. Collectively, our results suggest that arresten is a
potent inhibitor of angiogenesis with a potential for therapeutic use.
This article has been cited by other articles:
|
|
 |
|
  E. D. Karagiannis and A. S. Popel A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells PNAS, September 16, 2008; 105(37): 13775 - 13780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-P. Wu, M.-J. Young, C.-C. Tzeng, C.-R. Tzeng, K.-F. Huang, L.-W. Wu, and C.-Y. Chou A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer Carcinogenesis, June 1, 2008; 29(6): 1115 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Borza, D.-B. Borza, V. Pedchenko, M. A. Saleem, P. W. Mathieson, Y. Sado, H. M. Hudson, A. Pozzi, J. Saus, D. R. Abrahamson, et al. Human Podocytes Adhere to the KRGDS Motif of the {alpha}3{alpha}4{alpha}5 Collagen IV Network J. Am. Soc. Nephrol., April 1, 2008; 19(4): 677 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen and D. H. Gorski Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5 Blood, February 1, 2008; 111(3): 1217 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Horbelt, S.-Y. Lee, H. E. Mang, N. L. Knipe, Y. Sado, A. Kribben, and T. A. Sutton Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury Am J Physiol Renal Physiol, September 1, 2007; 293(3): F688 - F695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Boosani, A. P. Mannam, D. Cosgrove, R. Silva, K. M. Hodivala-Dilke, V. G. Keshamouni, and A. Sudhakar Regulation of COX-2 mediated signaling by {alpha}3 type IV noncollagenous domain in tumor angiogenesis Blood, August 15, 2007; 110(4): 1168 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kawaguchi, Y. Yamashita, M. Kanamori, R. Endersby, K. S. Bankiewicz, S. J. Baker, G. Bergers, and R. O. Pieper The PTEN/Akt Pathway Dictates the Direct {alpha}V{beta}3-Dependent Growth-Inhibitory Action of an Active Fragment of Tumstatin in Glioma Cells In vitro and In vivo Cancer Res., December 1, 2006; 66(23): 11331 - 11340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Meng, N. Ma, Z. Yan, W. Han, and Y. Zhang NGR Enhanced the Anti-Angiogenic Activity of tum-5 J. Biochem., August 1, 2006; 140(2): 299 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Borza, A. Pozzi, D.-B. Borza, V. Pedchenko, T. Hellmark, B. G. Hudson, and R. Zent Integrin {alpha}3beta1, a Novel Receptor for {alpha}3(IV) Noncollagenous Domain and a Trans-dominant Inhibitor for Integrin {alpha}vbeta3 J. Biol. Chem., July 28, 2006; 281(30): 20932 - 20939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wang, J. Sun, S. Kitamoto, M. Yang, A. Grubb, H. A. Chapman, R. Kalluri, and G.-P. Shi Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors J. Biol. Chem., March 3, 2006; 281(9): 6020 - 6029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Hall, F. R. Westwood, and P. F. Wadsworth Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate Toxicol Pathol, February 1, 2006; 34(2): 131 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nyberg, L. Xie, and R. Kalluri Endogenous Inhibitors of Angiogenesis Cancer Res., May 15, 2005; 65(10): 3967 - 3979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H.-K. Ma, J.-Y. Yao, L.-K. Yeh, S.-T. Liang, L.-C. See, H.-T. Chen, K.-Y. Lin, C.-C. Liang, K.-K. Lin, and J.-K. Chen In Vitro Antiangiogenic Activity in Ex Vivo Expanded Human Limbocorneal Epithelial Cells Cultivated on Human Amniotic Membrane Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2586 - 2595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Trochon-Joseph, D. Martel-Renoir, L. M. Mir, A. Thomaidis, P. Opolon, E. Connault, H. Li, C. Grenet, F. Fauvel-Lafeve, J. Soria, et al. Evidence of Antiangiogenic and Antimetastatic Activities of the Recombinant Disintegrin Domain of Metargidin Cancer Res., March 15, 2004; 64(6): 2062 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hamano, H. Sugimoto, M. A. Soubasakos, M. Kieran, B. R. Olsen, J. Lawler, A. Sudhakar, and R. Kalluri Thrombospondin-1 Associated with Tumor Microenvironment Contributes to Low-Dose Cyclophosphamide-Mediated Endothelial Cell Apoptosis and Tumor Growth Suppression Cancer Res., March 1, 2004; 64(5): 1570 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pedchenko, R. Zent, and B. G. Hudson {alpha}v{beta}3 and {alpha}v{beta}5 Integrins Bind Both the Proximal RGD Site and Non-RGD Motifs within Noncollagenous (NC1) Domain of the {alpha}3 Chain of Type IV Collagen: IMPLICATION FOR THE MECHANISM OF ENDOTHELIAL CELL ADHESION J. Biol. Chem., January 23, 2004; 279(4): 2772 - 2780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Floquet, S. Pasco, L. Ramont, P. Derreumaux, J. Y. Laronze, J. M. Nuzillard, F. X. Maquart, A. J. P. Alix, and J. C. Monboisse The Antitumor Properties of the {alpha}3(IV)-(185-203) Peptide from the NC1 Domain of Type IV Collagen (Tumstatin) Are Conformation-dependent J. Biol. Chem., January 16, 2004; 279(3): 2091 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. V. Soucy, M. A. Ihnat, C. D. Kamat, L. Hess, M. J. Post, L. R. Klei, C. Clark, and A. Barchowsky Arsenic Stimulates Angiogenesis and Tumorigenesis In Vivo Toxicol. Sci., December 1, 2003; 76(2): 271 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Panka and J. W. Mier Canstatin Inhibits Akt Activation and Induces Fas-dependent Apoptosis in Endothelial Cells J. Biol. Chem., September 26, 2003; 278(39): 37632 - 37636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Marcinkiewicz, P. H. Weinreb, J. J. Calvete, D. G. Kisiel, S. A. Mousa, G. P. Tuszynski, and R. R. Lobb Obtustatin: A Potent Selective Inhibitor of {alpha}1{beta}1 Integrin in Vitro and Angiogenesis in Vivo Cancer Res., May 1, 2003; 63(9): 2020 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sudhakar, H. Sugimoto, C. Yang, J. Lively, M. Zeisberg, and R. Kalluri Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha vbeta 3 and alpha 5beta 1 integrins PNAS, April 15, 2003; 100(8): 4766 - 4771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ortega and Z. Werb New functional roles for non-collagenous domains of basement membrane collagens J. Cell Sci., November 15, 2002; 115(22): 4201 - 4214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Funahashi, N. H. Sugi, T. Semba, Y. Yamamoto, S. Hamaoka, N. Tsukahara-Tamai, Y. Ozawa, A. Tsuruoka, K. Nara, K. Takahashi, et al. Sulfonamide Derivative, E7820, Is a Unique Angiogenesis Inhibitor Suppressing an Expression of Integrin {alpha}2 Subunit on Endothelium Cancer Res., November 1, 2002; 62(21): 6116 - 6123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. McDonald and P. Baluk Significance of Blood Vessel Leakiness in Cancer Cancer Res., September 15, 2002; 62(18): 5381 - 5385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Stupack and D. A. Cheresh ECM Remodeling Regulates Angiogenesis: Endothelial Integrins Look for New Ligands Sci. Signal., February 12, 2002; 2002(119): pe7 - pe7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Lin, J.-H. Chang, S. Jain, E. E. Gabison, T. Kure, T. Kato, N. Fukai, and D. T. Azar Matrilysin Cleavage of Corneal Collagen Type XVIII NC1 Domain and Generation of a 28-kDa Fragment Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2517 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zeisberg, G. Bonner, Y. Maeshima, P. Colorado, G. A. Muller, F. Strutz, and R. Kalluri Renal Fibrosis : Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation Am. J. Pathol., October 1, 2001; 159(4): 1313 - 1321. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. S. Pepper Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1104 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Ljubimova, A. J. Lakhter, A. Loksh, W. H. Yong, M. S. Riedinger, J. H. Miner, L. M. Sorokin, A. V. Ljubimov, and K. L. Black Overexpression of {alpha}4 Chain-containing Laminins in Human Glial Tumors Identified by Gene Microarray Analysis Cancer Res., July 1, 2001; 61(14): 5601 - 5610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yan and M. A. Moses A Case of Tumor Betrayal : Biphasic Effects of TIMP-1 on Burkitt's Lymphoma Am. J. Pathol., April 1, 2001; 158(4): 1185 - 1190. [Full Text] [PDF]
|
|
|
|
|
|
Y. Maeshima, P. C. Colorado, and R. Kalluri Two RGD-independent alpha vbeta 3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties J. Biol. Chem., July 28, 2000; 275(31): 23745 - 23750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maeshima, P. C. Colorado, A. Torre, K. A. Holthaus, J. A. Grunkemeyer, M. B. Ericksen, H. Hopfer, Y. Xiao, I. E. Stillman, and R. Kalluri Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane J. Biol. Chem., July 7, 2000; 275(28): 21340 - 21348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maeshima, M. Manfredi, C. Reimer, K. A. Holthaus, H. Hopfer, B. R. Chandamuri, S. Kharbanda, and R. Kalluri Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin J. Biol. Chem., April 27, 2001; 276(18): 15240 - 15248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maeshima, U. L. Yerramalla, M. Dhanabal, K. A. Holthaus, S. Barbashov, S. Kharbanda, C. Reimer, M. Manfredi, W. M. Dickerson, and R. Kalluri Extracellular Matrix-derived Peptide Binds to alpha vbeta 3 Integrin and Inhibits Angiogenesis J. Biol. Chem., August 17, 2001; 276(34): 31959 - 31968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rehn, T. Veikkola, E. Kukk-Valdre, H. Nakamura, M. Ilmonen, C. R. Lombardo, T. Pihlajaniemi, K. Alitalo, and K. Vuori Interaction of endostatin with integrins implicated in angiogenesis PNAS, January 30, 2001; 98(3): 1024 - 1029. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
